The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential Invokana cases for individuals who have suffered kidney failure, a heart attack, stroke or been hospitalized due to ketoacidosis following use of this new diabetes drug.

Invokana (canagliflozin) was introduced by Johnson & Johnson in March 2013, and has rapidly grown to become a blockbuster treatment for type 2 diabetes amid aggressive marketing. However, it now appears that the drug maker may have withheld important information about the potential risks users may face from Invokana side effects.

Financial compensation may be available through an Invokana lawsuit for individuals who have suffered:

  • Kidney Failure
  • Heart Attack
  • Stroke
  • Diabetic Ketoacidosis
  • Wrongful Death

To review whether you, a friend or family member may be eligible to pursue an Invokana injury claim, request a free consultation and case evaluation.

Invokana Kidney Failure and Ketoacidosis Problems

Invokana was the first member of a new class of diabetes drugs introduced in the U.S., known as sodium-glucose co-transporter 2 (SGLT2) inhibitors.

Invokana Lawyers

Invokana Lawyers

The lawyers at Saiontz & Kirk are investigating Invokana lawsuits for individuals throughout the United States. As a result of the drug maker’s failure to adequately warn, financial compensation may be available.


The medication works by inhibiting some kidney functions to increase the amount of sugar excreted in the urine. This was designed to increase glucose production and lower blood glucose levels among diabetics.

Although information about the potential injury risks with Invokana should have been known or suspected before the medication was introduced, lawsuits pursued on behalf of former users will allege that Johnson & Johnson failed to properly study the medication or adequately warn about serious side effects.

During the first year the medication was on the market, hundreds of reports involving Invokana problems were submitted to federal drug regulators, including reports of:

  • Kidney Failure
  • Kidney Impairment
  • Kidney Stones
  • Urinary Tract Infections
  • Abnormal Weight Loss
  • Hypersensitivity Reactions

The first information about the potential risk of problems with Invokana came in early 2015, when the FDA issued a drug safety communication about reports of users experiencing high levels of acid to accumulate in the blood; known as diabetic ketoacidosis.

In December 2015, the FDA announced that new Invokana warnings will be added to the drug label, indicating that patients should stop using the drug immediately and seek medical assistance if they began experiencing signs of ketoacidosis side effects, such as:

  • Difficulty Breathing
  • Nausea or Vomiting
  • Abdominal Pain
  • Confusion, Fatigue or Sleepiness

The FDA highlighted at least 73 adverse event reports received involving ketoacidosis with Invokana or other similar diabetes drugs. Each of the cases resulted in hospitalization or emergency room treatment.

Warnings were also added about the risk of urinary tract infections and kidney infections, which could lead to individuals suffering kidney failure from Invokana, and possibly wrongful death.

Allegations To Be Raised in Invokana Lawsuits

Invokana Lawsuits
  • Failure to Study Invokana Health Risks;
  • Failure to Warn about Risk of Ketoacidosis, Heart Attacks, Strokes or Kidney Failure from Invokana;
  • Misrepresenting the Safety of Invokana;
  • Failure to Issue an Invokana Recall

Invokana Class Action Lawyers

Individuals hospitalized due to ketoacidosis or diagnosed with kidney failure may be entitled to financial compensation through an Invokana class action lawsuit or individual injury claim.

Similar claims are being reviewed for users of other SGLT2 inhibitor diabetes drugs, including Invokamet lawsuits, Farxiga lawsuits, Xigduo XR lawsuits, Jardiance lawsuits and Glyxambi lawsuits. The makers of Invokana and these other new-generation diabetes drugs appear to have placed their desire for profits before consumer safety, by rushing the medications to the market.

Potential Invokana settlements may be available as a result of the drug maker’s alleged failure to properly research the risks, and apparent decision to withhold important safety information about serious and potentially life-threatening health problems from Invokana.

The Invokana lawyers at Saiontz & Kirk, P.A. provide free consultations and claim evaluations to help individuals determine whether they may be eligible to pursue a case. All lawsuits are pursued under a contingency fee agreement, which means that there are no out-of-pocket expenses to hire our Invokana law firm and we only receive attorney fees or expenses if a recovery is obtained.